Abstract
Authors studied 70 patients with panic disorder, 30 men and 40 women, mean age 34,5±1,8 years. All patients had insomnia. Patients were classified into the main and control groups. Patients of the control group received antidepressants only (fevarin in dosage 150 mg daily). Patients of the main group were additionally treated with mexidol (375 mg daily). The treatment duration was two weeks. A clinical and instrumental (polysomnography) examination revealed that the use of mexidol enhanced the decrease in anxiety disorders, autonomic disturbances and insomnia and improved quality of life of the patients.
Publication types
-
Comparative Study
-
Randomized Controlled Trial
MeSH terms
-
Adult
-
Antidepressive Agents, Second-Generation / administration & dosage
-
Antidepressive Agents, Second-Generation / therapeutic use
-
Dose-Response Relationship, Drug
-
Drug Therapy, Combination
-
Female
-
Fluvoxamine / administration & dosage
-
Fluvoxamine / therapeutic use*
-
Humans
-
Male
-
Panic Disorder / complications
-
Panic Disorder / drug therapy*
-
Panic Disorder / physiopathology
-
Picolines / administration & dosage
-
Picolines / therapeutic use*
-
Polysomnography
-
Sleep / drug effects
-
Sleep / physiology*
-
Sleep Wake Disorders / complications
-
Sleep Wake Disorders / drug therapy*
-
Sleep Wake Disorders / physiopathology
-
Treatment Outcome
Substances
-
Antidepressive Agents, Second-Generation
-
Picolines
-
emoxypine succinate
-
Fluvoxamine